Skip to main content
Login
Contact
Subscribe
Search form
Search
The Borger News-Herald
Home
Forms
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Service Directory
Photos
Videos
Games
Entertainment
Calendar
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Amarin Corp Ads
(NQ:
AMRN
)
5.790
USD
-0.200 (-3.34%)
Official Closing Price
Updated: 7:58 PM EST, Mar 8, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Amarin Corp Ads
< Previous
1
2
3
4
5
6
7
8
9
...
45
46
Next >
Amarin Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
February 25, 2021
From
GlobeNewswire News Releases
Amarin to Present at Two Upcoming Investor Conferences
February 18, 2021
From
GlobeNewswire News Releases
Amarin to Report Fourth Quarter and Full Year 2020 Results and Host Conference Call on February 25, 2021
February 17, 2021
From
GlobeNewswire News Releases
Amarin Provides Update on VASCEPA® (Icosapent Ethyl) Regulatory Review Processes in Mainland China and Hong Kong
February 09, 2021
From
GlobeNewswire News Releases
Amarin Receives Positive CHMP Opinion for Icosapent Ethyl for Cardiovascular Risk Reduction
January 29, 2021
From
GlobeNewswire News Releases
Amarin Expands Cardiovascular Risk Reduction Patent Infringement Lawsuit to Include Health Care Insurance Provider
January 25, 2021
From
GlobeNewswire News Releases
Icosapent Ethyl Included in the Chinese Society of Cardiology (CSC) Updated Guidelines for Primary Prevention of Cardiovascular Diseases
January 21, 2021
From
GlobeNewswire News Releases
Amarin Provides Preliminary 2020 Results and 2021 Outlook
January 07, 2021
From
GlobeNewswire News Releases
Amarin to Present at 39th Annual J.P. Morgan Healthcare Conference
January 04, 2021
From
GlobeNewswire News Releases
Amarin Highlights Multiple VASCEPA® (Icosapent Ethyl)-Related Scientific Findings Presented at National Lipid Association (NLA) Scientific Sessions 2020, Including First COVID-19 Clinical Results
December 14, 2020
From
GlobeNewswire News Releases
Amarin Reports Encouraging Efficacy and Safety Results from Pilot Study Treating COVID-19 Infected Outpatients with VASCEPA® (Icosapent Ethyl) in Late Breaker Presentation at National Lipid Associatio
December 12, 2020
From
GlobeNewswire News Releases
VASCEPA® (Icosapent Ethyl)-Related Scientific Findings to Be Presented at National Lipid Association (NLA) Scientific Sessions 2020
December 07, 2020
Amarin-Supported Research and Analyses from Academic Collaborators to Be Featured in Two Late Breaker and Six e-Poster Presentations, Including Encore of REDUCE-IT® EPA, Primary Results of the VASCEPA...
From
GlobeNewswire News Releases
Amarin Files Patent Infringement Lawsuit Against Hikma
November 30, 2020
From
GlobeNewswire News Releases
Amarin to Present at Piper Sandler’s 32nd Annual Healthcare Conference (Virtual)
November 24, 2020
From
GlobeNewswire News Releases
Amarin Shares Topline Data from Partner’s Pivotal Phase 3 Study of VASCEPA® (Icosapent Ethyl) in Mainland China
November 19, 2020
From
GlobeNewswire News Releases
Multiple New VASCEPA® (Icosapent Ethyl)-Related Scientific Findings Presented at American Heart Association’s Virtual Scientific Sessions 2020
November 18, 2020
From
GlobeNewswire News Releases
With Growing Incidence of Brain Cancer The Brain Tumor Drug Market Could Reach $3.4 Billion in 2022
November 17, 2020
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
With Growing Incidence of Brain Cancer The Brain Tumor Drug Market Could Reach $3.4 Billion in 2022
November 17, 2020
Financialnewsmedia.com News Commentary
From
PR Newswire
VASCEPA® (Icosapent Ethyl) Found to Significantly Reduce Ischemic Events in Patients with Prior Coronary Artery Bypass Grafting (CABG) Procedures in Post Hoc Subgroup Analyses of Landmark REDUCE-IT® S
November 13, 2020
From
GlobeNewswire News Releases
More Comprehensive Diagnostics are Needed as Cases Surge Once More
November 13, 2020
FinancialBuzz.com News Commentary
From
PR Newswire
Amarin to Present at the Stifel 2020 Virtual Healthcare and Jefferies Virtual London Healthcare Conferences
November 11, 2020
From
GlobeNewswire News Releases
Amarin Reports Third Quarter 2020 Financial Results and Provides Business Update
November 05, 2020
From
GlobeNewswire News Releases
New VASCEPA® (Icosapent Ethyl)-Related Scientific Findings to Be Presented at American Heart Association’s Virtual Scientific Sessions 2020
October 29, 2020
Amarin-Supported Research and Analyses from Academic Collaborators to Be Featured in Eight Presentations, Including REDUCE-IT® CABG (Coronary Artery Bypass Graft) Results and Additional Mechanism of...
From
GlobeNewswire News Releases
VASCEPA® (Icosapent Ethyl) Found to Significantly Reduce Cardiovascular Events in Patients with Compromised Renal Function at Baseline in Prespecified and Post Hoc Subgroup Analyses of Landmark REDUCE
October 26, 2020
From
GlobeNewswire News Releases
U.S. Veterans with Decreased Renal Function Shown to Be at Higher Risk for Adverse Cardiovascular Events if They Have Moderately Elevated Triglyceride (TG) Levels Despite Well-Controlled Low-Density L
October 23, 2020
New analysis of contemporary real-world data presented at American Society of Nephrology (ASN) Kidney Week 2020
From
GlobeNewswire News Releases
Amarin to Report Third Quarter 2020 Results and Host Conference Call on November 5, 2020
October 19, 2020
From
GlobeNewswire News Releases
VASCEPA® (Icosapent Ethyl) Found to Significantly Reduce Ischemic Events in Patients with Prior Percutaneous Coronary Intervention (PCI) in Post Hoc Subgroup Analyses of Landmark REDUCE-IT® Study Pres
October 15, 2020
From
GlobeNewswire News Releases
Thinking about buying stock in Ion Geophysical, TPI Composites, Coty, Tilray, or Amarin Corp?
October 08, 2020
InvestorsObserver issues critical PriceWatch Alerts for IO, TPIC, COTY, TLRY, and AMRN.
From
PR Newswire
Thinking about buying stock in ImmunoGen, Lithium Americas Corp, Cytokinetics, Kosmos Energy, or Amarin Corp?
October 05, 2020
InvestorsObserver issues critical PriceWatch Alerts for IMGN, LAC, CYTK, KOS, and AMRN.
From
PR Newswire
Latest Research Evaluating VASCEPA® (Icosapent Ethyl) Mechanisms of Action Presented at European Atherosclerosis Society (EAS) Congress 2020
October 05, 2020
Data presented provides additional insight into potential mechanisms by which VASCEPA lowers cardiovascular risk
From
GlobeNewswire News Releases
< Previous
1
2
3
4
5
6
7
8
9
...
45
46
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.